白敬宇品牌怎么样 申请店铺

我要投票 白敬宇在医疗用品行业中的票数:67 更新时间:2024-12-23
白敬宇是哪个国家的品牌?「白敬宇」是 南京白敬宇制药有限责任公司 旗下著名品牌。该品牌发源于江苏,由创始人陈在1991-07-12期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
白敬宇怎么样

南京白敬宇制药是一家生产化学原料药及制剂药的综合性制药公司,首批“中华老字号”和江苏省高新技术企业。公司前身“白敬宇眼药厂”1937年在南京成立,“白敬宇”商标于1939年注册,是中国为数极少的民国时期药品注册商标之一,2011年被国家工商总局认定为“中国驰名商标”。公司现有员工近800人,近三年累计产销和利税分别为12.67亿元和1.16亿元,2012年在岗员工人均可支配收入6.22万元。

公司原料药和制剂药生产基地分别位于六合化学工业园区和新港经济技术开发区,两个厂区绿树成荫,均为园区的“园林式工厂”,在2010-2011年先后通过了ISO9001质量体系认证、ISO14001环境管理体系认证以及ISO18001职业健康安全管理体系的认证,在同类企业中处于领先地位。

公司现有注册产品120个,其中原料药27个,制剂药93个。制剂药有片剂、膏剂、胶囊剂、散剂、酊剂、混悬液剂、凝胶剂等15个剂型,主要产品有心脑血管、祛痰镇咳、抗感染、维生素类、眼用膏剂等系列品种,有26个产品进入国家基本药物目录。主要剂型的年最大产量为:片剂80亿片,激素药20亿片,酊水100万升,膏剂6500万支,胶囊剂6.5亿粒,混悬剂45万升、洗剂5万升、散剂9000万包。公司另有24个品规的制剂药产品在12个国家取得了药品注册证书,产品销售到38个国家和地区。公司原料药常年生产盐酸左旋咪唑、酮康唑、氯霉素及酮酸钙等产品,年生产能力大于1000吨。原料药3个主要品种已在欧洲、美国、日本、俄罗斯等国注册销售。

公司的“国际合作”理念决定了公司对原料生产区的环保治理具有超前意识,按照国际惯例,客户在接受产品前必须对企业进行严格的全面质量审计,其中“人的安全和环境保护”是审计的重要项目,因此,供应商审计是公司能够不断进步的动力。2006年至今,原料药厂区共接受国外供应商审计20余次,其中有美国通用、比利时杨森、德国拜耳、西班牙因杜肯等国际性大公司,公司现已成为上述公司的产品供应商。

公司是南京市药品出口产量最大的企业,尤其是制剂药出口更是领先,自营出口1千万美元,出口供货值1亿元人民币。公司以“做好产品、卖好产品”为宗旨,致力于实业拓展。公司的目标是:到2014年,产品制造水平要达到国内一流、国际中等以上标准,以满足不同市场的客户需要,确保企业可持续发展。

Nanjing Baijingyu Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company that produces chemical raw materials and pharmaceutical preparations. It is one of the first batch of "Chinese time-honored brands" and high-tech enterprises in Jiangsu Province. The company's predecessor, Bai Jingyu eye pharmaceutical factory, was established in Nanjing in 1937. The trademark of Bai Jingyu was registered in 1939. It is one of the few drug registered trademarks in the Republic of China. In 2011, it was recognized as "China's famous trademark" by the State Administration of industry and Commerce. The company has nearly 800 employees. In the past three years, the cumulative production and sales and profits and taxes are RMB 1.267 billion and RMB 116 million respectively. In 2012, the average disposable income of on-the-job employees is RMB 62200. The company's API and pharmaceutical production bases are respectively located in Liuhe chemical industry park and Xingang economic and Technological Development Zone. Both of the two plants are "garden type factories" in the park. From 2010 to 2011, they have passed ISO9001 quality system certification, ISO14001 environmental management system certification and ISO18001 occupational health and safety management system certification, and are in the leading position among similar enterprises First place. The company has 120 registered products, including 27 APIs and 93 pharmaceutical preparations. Preparations include tablets, ointments, capsules, powder, tincture, suspension, gel and other 15 formulations. The main products are cardiovascular, expectorant, antitussive, anti infective, vitamin, eye paste and other varieties. 26 products have entered the national essential drug list. The annual maximum production of main dosage forms is: 8 billion tablets, 2 billion hormone drugs, 1 million liters tincture water, 65 million plasters, 650 million capsules, 450000 liters suspension, 50000 liters lotion and 90 million packages powder. Another 24 pharmaceutical products of the company have obtained drug registration certificates in 12 countries, and the products have been sold to 38 countries and regions. The company's APIs produce levamisole hydrochloride, ketoconazole, chloramphenicol, calcium ketoacid and other products throughout the year, with an annual production capacity of more than 1000 tons. Three main varieties of APIs have been registered and sold in Europe, the United States, Japan, Russia and other countries. The company's concept of "international cooperation" determines that the company has an advanced awareness of environmental protection in the raw material production area. According to international practice, customers must conduct a strict overall quality audit on the enterprise before accepting products. Among them, "human safety and environmental protection" is an important audit project. Therefore, supplier audit is the driving force for the company to make continuous progress. Since 2006, the API plant area has been audited by foreign suppliers for more than 20 times, among which there are international large companies such as general motors of the United States, Janssen of Belgium, Bayer of Germany, induken of Spain, etc. the company has become the product supplier of the above companies. The company is the largest pharmaceutical export enterprise in Nanjing, especially the leading pharmaceutical export, with self export of US $10 million and export supply value of RMB 100 million. With the tenet of "do well in products and sell well in products", the company is committed to industrial development. The company's goal is: by 2014, the product manufacturing level should reach the domestic first-class, international medium-sized and above standards, so as to meet the needs of customers in different markets and ensure the sustainable development of the enterprise.

本文链接: https://brand.waitui.com/ba0510fe3.html 联系电话:02586504321

千城特选小程序码

7×24h 快讯

日本监管机构拟以涉嫌垄断为由勒令谷歌整改,公司回应

日本公平交易委员会拟以涉嫌违反《反垄断法》为由向谷歌发出整改令。该委员会认为,谷歌涉嫌违规要求智能手机厂家优先预装谷歌搜索APP。据了解,日本公平交易委员会已向谷歌发出处分方案通知,将在倾听意见之后正式做出处分决定。谷歌在一份声明中表示:“我们将继续与日本政府密切合作,展示我们如何在日本支持安卓生态系统并扩大用户选择。”该公司称,将在听证过程中提出其论据。谷歌还表示,日本公平交易委员会未充分考虑公司提出的解决方案,对此感到失望。(财联社)

2小时前

《穿越火线》项目正式成为2025年EWC电子竞技世界杯比赛项目

36氪获悉,12月23日,第一人称射击产品《穿越火线》以其在80余个国家及地区超10亿用户的庞大体量,及2024CFS在中国的超凡影响力,正式成为2025年电子竞技世界杯(EWC)赛事阵容中的一员,进一步拓展了穿越火线赛事的全球影响力与受众覆盖范围。

2小时前

中国中车:全资子公司将所持装备公司80%股权无偿划转至公司

36氪获悉,中国中车公告,公司全资子公司中车资产管理有限公司将所持北京北车中铁轨道交通装备有限公司(简称“装备公司”)80%股权无偿划转至公司。本次划转完成后,装备公司将成为公司一级子公司。该议案在董事会上获得全票通过。

2小时前

微信“送礼物”功能上线,顺丰同城即配服务同步就位

36氪获悉,近日,微信灰度测试微信小店“送礼物”功能,并发布相关使用指南,除珠宝与教育培训两大类目外,其他类目的微信小店,原价万元以内的商品,都将默认支持该功能。据了解,顺丰同城正积极搭建微信送礼即配场景方案,满足同城礼物急送需求。针对生鲜水产等高时效要求、贵重礼品等高安全需求、以及用户期望更快收到礼物等场景,顺丰同城已为发货地与收礼方地址处于同城的商家和订单搭建即配解决方案。

2小时前

豪鹏科技:上调再次回购股份价格上限至77.56元/股

36氪获悉,豪鹏科技公告,为保障再次回购股份方案的顺利实施,将再次回购股份方案的回购价格上限由59.00元/股调整为77.56元/股,该回购价格上限未超过董事会审议通过相关议案并形成决议前30个交易日公司股票交易均价的150%。回购股份价格上限调整生效日期为2024年12月24日。

2小时前

本页详细列出关于东阳光HEC的品牌信息,含品牌所属公司介绍,东阳光HEC所处行业的品牌地位及优势。
咨询